A significant percentage of patients with Lyme arthritis and other Lyme disease manifestations were positive for anti-RA33 antibodies.

EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

No dedicated clinical trials have compared denosumab and bisphosphonates for fracture prevention in patients on dialysis.

For individuals reporting cannabis use, the odds of opioid misuse are reduced among individuals in states with medical cannabis legalization.

Higher intake of red meat is associated with an increased risk for developing dementia and subjective cognitive decline.

Zoledronate administered at baseline and five years is effective for preventing morphometric vertebral fracture.

A recent study finds that the risk for myalgic encephalomyelitis/chronic fatigue syndrome is increased following COVID-19.

Heterozygous FMF can be monitored using S100A8/A9 and S100A12 levels, with colchicine discontinuation possible among patients with this genotype.

Primary ovarian insufficiency was associated with a higher risk for autoimmune conditions including hypothyroidism and adrenal insufficiency.

The use of short-term hormone therapy for menopause is not associated with long-term cognitive impact after 10 years.

According to a recent study, the lifetime risk of dementia in a community-based cohort is 42 percent after age 55 years.

The USPSTF recommends osteoporosis screening to prevent osteoporotic fractures for all women aged 65 years and older.